[A12-03] Belatacept -Benefit assessment according to § 35a Social Code Book V (dossier assessment)
Last updated 16.04.2012
Project no.:
A12-03
Commission:
Commission awarded on 16.01.2012 by the Federal Joint Committee (G-BA).
Report type:
Dossier assessment
Status:
Commission completed
Department/Division:
Drug Assessment
Topic:
Immune system and infections, Kidneys and urinary system, Surgery
Note:
After completion of the assessment by IQWiG the Federal Joint Committee (G-BA) conducts a commenting procedure. This may provide supplementary information and as a result lead to a modified benefit assessment. Further information and the decision on the early benefit assessment can be found on the relevant page of the G-BA website.
| Project no. | Title | Status |
|---|---|---|
| A15-25 | Belatacept - Benefit assessment according to § 35a Social Code Book V (dossier assessment) | Commission completed |
| A11-13 | Belatacept - Consultation on the content and completeness of the dossier | Commission completed |
Federal Joint Committee (G-BA)
2012-07-05 A G-BA decision was published.